HAO on Nasdaq
Haoxi Health Technology Ltd
Haoxi Health Technology Ltd is a limited liability company incorporated on September 26.1
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with Starco Brands, Inc., Stran & Company, Inc. or KIDOZ INC., or pick any stock.
- TickerHAO on Nasdaq1
- IndustryServices-Advertising Agencies1
- HeadquartersE91
- Incorporated inCayman Islands3
- Business address801/802, Tower C, Building 103, Huizhongli, Chaoyang District, Beijing, 1001013
- Filer categoryNon-accelerated filer, Emerging growth company3
See how the biggest companies compare on our leaderboards
Haoxi Beijing is a limited liability company incorporated on September 26, 2018 under the laws of China. It was formerly known as Beijing Haoxi Culture Media Co., Ltd. On September 4, 2020, Haoxi Beijing changed its name to Beijing Haoxi Digital Technology Co., Ltd.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2026
Where the money goes
Where each dollar of revenue went, fiscal 2026
- Cost of revenue99¢$54.2M
- Research and development0¢$104.4K
- Other costs1¢$488.1K
- Income tax0¢$36.6K
Out of $54.8M in revenue.2 The company lost money this year.
Financial statements
No quarterly figures reported.
Every line of the income statement as filed: the last 3 fiscal years, latest first.2
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Revenues | $54.8M | $32.8M | $48.5M |
| Cost of revenues | $54.2M | $31.9M | $45.8M |
| Gross profit | $629.1K | $927.8K | $2.8M |
| General and administrative expenses | $8.6M | $2.8M | $911.5K |
| Selling and marketing expenses | $78.9K | $50.2K | $41.6K |
| Research and development expenses | $104.4K | $79.5K | $80.0K |
| Impairment loss on non-current assets | $1.5M | ||
| Total operating expenses | $10.3M | $2.9M | $1.0M |
| (Loss) income from operations | -$9.7M | -$2.0M | $1.7M |
| Interest expense | -$52.4K | -$46.0K | -$41.2K |
| Interest income | $216.8K | $363.3K | $76.1K |
| Issuance costs allocated to warrant liability | -$919.0K | ||
| Change in fair value of warrant liability | $6.8M | ||
| Other income (expense) | $107 | -$12.5K | -$16.9K |
| Total other income (loss), net | $164.5K | $6.1M | $18.0K |
| (Loss) income before income taxes | -$9.5M | $4.1M | $1.7M |
| Income tax expense | -$36.6K | -$270.7K | -$443.6K |
| Net (loss) income | -$9.5M | $3.9M | $1.3M |
| Foreign currency translation gain (loss) | $128.8K | -$1.1K | $387 |
| Total comprehensive (loss) income | -$9.4M | $3.9M | $1.3M |
| Earnings (loss) earnings per share - basic | -$386.40 | $4,251.81 | $2,701.53 |
| Earnings (loss) earnings per share - diluted | -$386.40 | $3,385.53 | $2,701.53 |
| Weighted average shares outstanding - basic | 24.7K shares | 912 shares | 478 shares |
| Diluted (in Shares) | 24.7K shares | 936 shares | 478 shares |
No quarter-by-quarter statement was filed.
No quarterly figures reported.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.2
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | $10.9M | $8.6M | ||
| Accounts receivables, net | $5.9K | $460.3K | ||
| Advances to suppliers, net | $5.7M | $5.7M | ||
| Prepayments, receivables and other assets, net | $129.3K | $4.8M | ||
| Total current assets | $16.8M | $19.6M | ||
| Investment in convertible bond | $4.7M | |||
| Property and equipment, net | $104.2K | $108.9K | ||
| Intangible assets | $1.8M | |||
| Operating right-of-use asset | $79.2K | |||
| Total non-current assets | $4.8M | $2.0M | ||
| Total Assets | $21.6M | $21.6M | ||
| Short-term loans | $1.3M | $1.3M | ||
| Accounts payables | $160.1K | $153.9K | ||
| Advance from customers | $667.6K | $537.6K | ||
| Taxes payable | $1.2M | $1.3M | ||
| Accrued expenses and other liabilities | $1.0K | |||
| Salary and welfare payable | $24.7K | $32.3K | ||
| Warrant liability | $1.4K | $104.4K | ||
| Operating right-of-use liabilities-current | $79.2K | |||
| Principal Amount | $290.7K | $300.3K | ||
| Long-term accounts payable-current | $26.5K | |||
| Total current liabilities | $3.7M | $3.9M | ||
| Long-term borrowing | $307.3K | |||
| Total non-current liabilities | $307.3K | |||
| Total Liabilities | $3.7M | $4.2M | ||
| Additional paid-in capital | $22.0M | $12.8M | ||
| Statutory reserves (in Dollars) | $7.3K | |||
| (Accumulated deficit) Retained earnings | -$4.9M | $4.6M | ||
| Accumulated other comprehensive income (loss) | $83.3K | -$45.5K | ||
| Total shareholders equity | $17.9M | $17.4M | $11.3M | $1.6M |
| Total liabilities and shareholders equity | $21.6M | $21.6M | ||
| Ordinary shares par value (in Dollars per share) | $0.32 | $0.00 |
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | $10.9M | $8.6M | ||
| Accounts receivables, net | $5.9K | $460.3K | ||
| Advances to suppliers, net | $5.7M | $5.7M | ||
| Prepayments, receivables and other assets, net | $129.3K | $4.8M | ||
| Total current assets | $16.8M | $19.6M | ||
| Investment in convertible bond | $4.7M | |||
| Property and equipment, net | $104.2K | $108.9K | ||
| Intangible assets | $1.8M | |||
| Operating right-of-use asset | $79.2K | |||
| Total non-current assets | $4.8M | $2.0M | ||
| Total Assets | $21.6M | $21.6M | ||
| Short-term loans | $1.3M | $1.3M | ||
| Accounts payables | $160.1K | $153.9K | ||
| Advance from customers | $667.6K | $537.6K | ||
| Taxes payable | $1.2M | $1.3M | ||
| Accrued expenses and other liabilities | $1.0K | |||
| Salary and welfare payable | $24.7K | $32.3K | ||
| Warrant liability | $1.4K | $104.4K | ||
| Operating right-of-use liabilities-current | $79.2K | |||
| Principal Amount | $290.7K | $300.3K | ||
| Long-term accounts payable-current | $26.5K | |||
| Total current liabilities | $3.7M | $3.9M | ||
| Long-term borrowing | $307.3K | |||
| Total non-current liabilities | $307.3K | |||
| Total Liabilities | $3.7M | $4.2M | ||
| Additional paid-in capital | $22.0M | $12.8M | ||
| Statutory reserves (in Dollars) | $7.3K | |||
| (Accumulated deficit) Retained earnings | -$4.9M | $4.6M | ||
| Accumulated other comprehensive income (loss) | $83.3K | -$45.5K | ||
| Total shareholders equity | $17.9M | $17.4M | $11.3M | $1.6M |
| Total liabilities and shareholders equity | $21.6M | $21.6M | ||
| Ordinary shares par value (in Dollars per share) | $0.32 | $0.00 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.2
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Net Income (Loss) | -$9.5M | $3.9M | $1.3M |
| Depreciation and amortization | $308.6K | $294.6K | $10.6K |
| Amortization of right-of-use assets | $80.9K | $77.1K | |
| Provision for doubtful accounts | $6.0M | $19.5K | |
| Share-based payment | $58.6K | ||
| Change in fair value of warrant liability | -$6.8M | ||
| Issuance costs allocated to warrant liability | $919.1K | ||
| Convertible bond investment-Interest | -$152.2K | ||
| Impairment loss on non-current assets | $1.5M | ||
| Accounts receivables | $439.6K | -$254.0K | -$217.9K |
| Advances to suppliers | -$1.2M | -$548.6K | -$2.7M |
| Prepayments, receivables and other assets | $171.7K | -$777 | -$175.3K |
| Accounts payable | -$1.6K | -$496.8K | $623.2K |
| Advance from customers | $99.7K | -$642.1K | -$328.1K |
| Accrued expenses and other liabilities | -$2.2K | -$104.5K | $60.1K |
| Amount due to related parties, current | -$55.9K | $55.9K | |
| Taxes payable | -$132.8K | $267.3K | $708.7K |
| Long-term accounts payable | -$27.1K | -$39.6K | |
| Operating lease right-of-use assets | -$90.4K | ||
| Operating lease liabilities | -$80.9K | -$77.1K | $90.4K |
| Salary and welfare payable | -$8.8K | -$2.0K | $3.4K |
| Net cash used in operating activities | -$2.6M | -$3.4M | -$747.6K |
| Purchase of property and equipment | -$55.4K | ||
| Purchases of intangible assets | -$2.1M | ||
| Purchases of investments in convertible bond | -$4.5M | ||
| Repayments of third parties | $1.0M | ||
| Loans to related party | -$1.0M | ||
| Repayment of related party | $1.0M | ||
| Loans to third parties | -$2.5M | -$3.1M | |
| Net cash used in investing activities | -$4.5M | -$3.6M | -$3.1M |
| Proceeds from short-term borrowings | $1.3M | $2.0M | $478.4K |
| Repayment of short-term borrowings | -$1.3M | -$1.2M | -$115.9K |
| Repayment of long-term borrowings | -$338.4K | ||
| Repayment of due to a related party | -$14.3K | ||
| Proceeds from the follow-on offering | $12.8M | $11.0M | |
| Proceeds from IPO (a shareholder) | $9.0M | ||
| Cost directly related to the issuing new shares | -$3.0M | -$2.8M | |
| Net cash provided by financing activities | $9.3M | $8.9M | $9.3M |
| Effect of foreign exchange rate on cash and restricted cash | $55.9K | -$1.7K | $5.6K |
| Net increase in cash | $2.3M | $2.0M | $5.5M |
| Right-of-use assets obtained in exchange for new operating lease liabilities | $79.2K | ||
| Liability extinguished upon exercise of warrants | $103.0K | $9.7M | |
| Initial issuance cost of warrants allocated to equity | $125.3K | ||
| Income taxes paid | $3.9K | $7.3K | $27.6K |
| Interest paid | $34.0K | $43.3K | $37.3K |
No quarter-by-quarter statement was filed.
Corporate structure
Haoxi Health Technology Ltd sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Haoxi Health Technology Ltd
- METEORA CAPITAL, LLC Filed SCHEDULE 13G/A on Haoxi Health Technology Ltd, latest May 15, 2025 (2 filings since Feb 14, 2025)
- Haoxi Health Technology Ltd E9
Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Haoxi Health Technology Ltd reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $163.7K2 Jun 30, 2026 | $155.8K2 Jun 30, 2025 | +5.1% |
| Accumulated depreciation | $59.5K2 Jun 30, 2026 | $46.9K2 Jun 30, 2025 | +27.1% |
| Property and equipment, net | $104.2K2 Jun 30, 2026 | $108.9K2 Jun 30, 2025 | −4.3% |
| Operating-lease assets (leased space) | $79.2K2 Jun 30, 2025 | $89.5K5 Jun 30, 2023 | −11.6% |
Investments
Intangibles and goodwill
Leadership
Who has led Haoxi Health Technology Ltd, and when. Pick a name to see everywhere that person has worked.
Board members and other officers (2)
- Board memberChangmao Su Apr 2, 2026 to now7
- Board memberChuanjie Hu Apr 2, 2026 to now8
Filings
105 filings to the SEC since October 2021: 3 annual reports, 7 insider forms, 2 large holders, 93 other. The latest 20:
- Sep 30, 202620-F ANNUAL REPORT EDGAR
- Jul 13, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Jul 13, 2026424B5 PROSPECTUS SUPPLEMENT EDGAR
- Jul 6, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Jun 24, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Jun 4, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- May 21, 20266-K CURRENT REPORT EDGAR
- May 20, 20264 EDGAR
- May 19, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- May 13, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- May 12, 2026424B5 PROSPECTUS SUPPLEMENT EDGAR
- Apr 22, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Apr 6, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Apr 6, 20263 EDGAR
- Apr 2, 20263 EDGAR
- Apr 2, 20263 EDGAR
- Apr 2, 20263 EDGAR
- Apr 2, 20263 EDGAR
- Mar 19, 20263 EDGAR
- Mar 6, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
The 105 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
1 open-market trades by officers, directors and large owners since October 2021: 1 buys and 0 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| May 19, 2026 | Fan ZhenCEO & Chairman | Buy | 40,000,000 | $0.02 | $800.0K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- METEORA CAPITAL, LLCSCHEDULE 13G/A, 2 filings Feb 14, 2025 to May 15, 20259
SEC filer profile
How Haoxi Health Technology Ltd is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARHaoxi Health Technology Ltd1
- CIK0001954594
- Filer statusNon-accelerated filer an emerging growth company; not a shell company4
- Incorporated inCayman Islands4
- Fiscal year endsJune 301
- Industry code (SIC)7311 Services-Advertising Agencies1
- SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance1
- Business address801/802, Tower C, Building 103, Huizhongli, Chaoyang District, Beijing, China 100101, China1
- Phone86-10-133115879761
- Shares outstanding95,232 Common Class A shares; 15,895 Common Class B shares as of Jun 30, 20264
- AuditorHCL, PLLC, Chicago, IL PCAOB ID 7222; no auditor attestation of internal control over financial reporting4
- On EDGAR sinceFeb 15, 20231
- Filings105 in all: 6-K (30), CORRESP (16), F-1/A (13), UPLOAD (12), 3 (6), 20-F (3), 424B5 (3), DRS/A (3)1
All 20 form types
DRSLTR (3), EFFECT (3), 424B4 (2), DRS (2), F-1 (2), 4 (1), 8-A12B (1), CERT (1), F-3 (1), F-3/A (1), SCHEDULE 13G (1), SCHEDULE 13G/A (1)
- Latest filingsAnnual report (20-F) Sep 30, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Class A Ordinary Shares, par value US$0.000002 per share | HAO | The Nasdaq Stock Market |
From the cover page of the 20-F filed Sep 30, 2026 (Section 12(b) of the Exchange Act).4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7SEC EDGARChangmao Su, Board member
- 8SEC EDGARChuanjie Hu, Board member
- 9